# A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.

> **NCT06028490** · PHASE2 · UNKNOWN · sponsor: **Zheng Liu ENT** · enrollment: 90 (estimated)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **BIOLOGICAL:** GR1802 injection-1
- **BIOLOGICAL:** GR1802 injection-2
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06028490
- **Lead sponsor:** Zheng Liu ENT
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-07
- **Primary completion:** 2023-11
- **Final completion:** 2023-11
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06028490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06028490, "A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06028490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*